» Articles » PMID: 1370059

Optimization of Cell Culture Conditions for G-CSF (granulocyte-colony Stimulating Factor) Production by Genetically Engineered Namalwa KJM-1 Cells

Overview
Journal Cytotechnology
Specialties Biotechnology
Genetics
Date 1991 Sep 1
PMID 1370059
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

An expression vector for G-CSF, pASLB3-3, was constructed and introduced into Namalwa KJM-1 cells (Hosoi et al., 1988), and cells resistant to 100 nM of methotrexate (MTX) were obtained. Among them, the highest producer, clone SC57, was selected and the productivity of this clone was further characterized. The maximal production of G-CSF was at the most 1.8 micrograms/ml/day using a 25 cm2 tissue culture flask, even though the cell number was above 7 x 10(5) cells/ml. The limiting factors at high density were analyzed as the deficiency of nutrients, such as glucose, cysteine and serine, and pH control. The depression of specific G-CSF productivity per cell under the batch culture conditions was overcome by using a perfusion culture system, Biofermenter (Sato, 1983) with modifications of nutrients supplementation by a dialysis membrane and/or dissolved oxygen (DO) supplementation by microsilicone fibers. ITPSGF medium was modified to elevate concentrations of amino acids and glucose by 2.0- and 2.5-times, respectively. Under the control of pH at 7.4 and DO at 4 ppm, the specific G-CSF productivity was not depressed even at high cell density (above 1 x 10(7) cells/ml), and the amount of G-CSF reached 41 micrograms/ml. These results indicated the possibility of finding the optimum culture conditions for the production of recombinant proteins by Namalwa KJM-1 cells.

Citing Articles

The effect of different media composition and temperatures on the production of recombinant human growth hormone by CHO cells.

Rezaei M, Zarkesh-Esfahani S, Gharagozloo M Res Pharm Sci. 2013; 8(3):211-7.

PMID: 24019831 PMC: 3764673.


Effect of culture temperature on a recombinant CHO cell line producing a C-terminal α-amidating enzyme.

Furukawa K, Ohsuye K Cytotechnology. 2012; 26(2):153-64.

PMID: 22358553 PMC: 3466681. DOI: 10.1023/A:1007934216507.


Modulation of oligosaccharide structure of a pro-urokinase derivative (pro-UK delta GS1) by changing culture conditions of a lymphoblastoid cell line Namalwa KJM-1 adapted to serum-free medium.

Hosoi S, Satoh M, Higo K, Sugimoto S, Miyaji H, Karasawa A Cytotechnology. 1995; 19(2):125-35.

PMID: 8987501 DOI: 10.1007/BF00749767.


Stabile production of a thrombin resistant pro-urokinase derivative (PRO-UKS1) by Namalwa KJM-1 cells adapted to serum-free medium.

Hosoi S, Satoh M, Miyaji H, Nishi T, Mizukami T, Hasegawa M Cytotechnology. 1995; 19(1):1-10.

PMID: 8987499 DOI: 10.1007/BF00749750.


Efficient expression of pro-urokinase by human lymphoblastoid Namalwa KJM-1 cells using moloney retroviral promoter.

Satoh M, Miyaji H, Nishi T, Mizukami T, Sato S, Itoh S Cytotechnology. 1995; 18(3):167-72.

PMID: 8920107 DOI: 10.1007/BF00767764.


References
1.
Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

2.
Miyaji H, Harada N, Mizukami T, Sato S, Fujiyoshi N, Itoh S . Expression of human lymphotoxin in Namalwa KJM-1 cells adapted to serum-free medium. Cytotechnology. 1990; 4(1):39-43. DOI: 10.1007/BF00148809. View

3.
Smiley A, Hu W, Wang D . Production of human immune interferon by recombinant mammalian cells cultivated on microcarriers. Biotechnol Bioeng. 1989; 33(9):1182-90. DOI: 10.1002/bit.260330914. View

4.
Miyaji H, Harada N, Mizukami T, Sato S, Fujiyoshi N, Itoh S . Efficient expression of human beta-interferon in Namalwa KJM-1 cells adapted to serum-free medium by a dhfr gene coamplification method. Cytotechnology. 1990; 4(2):173-80. DOI: 10.1007/BF00365098. View

5.
Nagata S, Tsuchiya M, Asano S, Kaziro Y, Yamazaki T, Yamamoto O . Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. Nature. 1986; 319(6052):415-8. DOI: 10.1038/319415a0. View